| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |